Cited by — Correction to: Real-world clinical outcomes and economic burden of discontinuation of taxane therapy among patients with metastatic castration-resistant prostate cancer | ResearchHub - ResearchHub
Research graph
Cited by
Admitted local publications that cite Correction to: Real-world clinical outcomes and economic burden of discontinuation of taxane therapy among patients with metastatic castration-resistant prostate cancer.
No admitted local citation edges point to this work yet.
